Furthermore, several findings suggest that a reduction of ERK1/2 signaling, another component of the MAPK insulin pathway, may increase androgen biosynthesis [53, 59, 60] and be intrinsic to PCOS women [59]. The gene discussed is MAPK3; the disease is polycystic ovary syndrome.